Search

Peripheral Giant Cell Granuloma (PGCG) is the most common benign and reactive hyperplastic giant cell lesion of the oral cavity originating either from the periodontal ligament or the periosteum of the adjacent tooth. The lesion has high recurrence rate, fast growing and sometimes cortical plates of the adjoining interdental bones are involved. Proper diagnosis is essential to differentiate it from other giant cell lesions of the oral cavity which is based on clinical, Dental implants are a popular option for tooth replacement due to their biocompatibility, strength, and durability. However, biocorrosion and the release of titanium particles from these implants have raised concerns, as they may contribute to peri-implantitis, a common inflammatory disease. Studies show that peri-implantitis sites exhibit more particles than healthy sites, with these particles found around implants and within epithelial cells, connective tissue, macrophages, and bone. Bio-corrosion, a complex process leading to implant failure, releases metallic particles into surrounding tissues, causing inflammation and tissue damage. Peri-implantitis, a bacterial infection, affects tissues around the implant, resulting in bone loss and potential implant failure. Factors influencing these complications include implant design, material properties, patient radiological and histopathological findings. Surgical excision along with curettage and peripheral osteotomy is the choice of treatment to prevent recurrence. The present paper reports a case of PGCG in the maxillary anterior region of an 8-year-old male child along with its diagnosis and management. [ABSTRACT FROM AUTHOR]

This article discusses the delayed occurrence of foreign body reactions caused by poly-L-lactic acid (PLLA) fillers, which are commonly used for tissue augmentation and cosmetic purposes. The article presents a case study of a 52-year-old woman who developed granuloma formation over 100 months after receiving PLLA injections in the nasolabial fold. The article emphasizes the importance of healthcare providers recognizing the potential adverse effects of PLLA fillers and informing patients about these risks. It also highlights the effectiveness of intralesional steroid therapy in managing complications associated with PLLA injections. [Extracted from the article]